Eric Vincent Cabahug , NP
Nurse Practitioner β’ Torrance, CA
1000 W Carson St # 449
Torrance, CA 905022004
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 19, 2020; this date does not establish years in practice.
-
Published CMS data list 805 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Biktarvy (Bictegrav/Emtricit/Tenofov Ala) β 111 prescription fills, including refills.
- Atorvastatin Calcium β 77 prescription fills, including refills.
- Symtuza (Darunavir/Cob/Emtri/Tenof Alaf) β 60 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 29 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Torrance, CA (2024, 32 clinicians with data). Median for this group: 258. Middle half: 89 to 741.
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in California (2024, 3,221 clinicians with data). Median for this group: 248. Middle half: 63 to 852.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 137 in 2021 to 805 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2021β2024.
Practice Location & Contact Primary Location
1000 W Carson St # 449
Torrance, CA 905022004
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
933 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$933,808 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,329.98 across 45 records.
By nature of payment
- Food and Beverage: $1,329.98 across 45 records.
Reporting-company totals (3 largest of 4)
- Gilead Sciences, Inc.: $860.42 across 27 records.
- ViiV Healthcare Company: $342.47 across 13 records.
- Merck Sharp & Dohme LLC: $110.62 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2020
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Torrance and California
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Torrance, CA (2024, 32 clinicians with data). Median for this group: 258. Middle half: 89 to 741.
More Part D prescriptions than 70% of clinicians listed under Nurse Practitioner in California (2024, 3,221 clinicians with data). Median for this group: 248. Middle half: 63 to 852.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Nurse Practitioner in Torrance, CA (2024, 32 clinicians with data). Median for this group: $21,436. Middle half: $5,851 to $69,426.
A higher Part D drug cost than 95% of clinicians listed under Nurse Practitioner in California (2024, 3,221 clinicians with data). Median for this group: $13,982. Middle half: $995 to $121,041.
80 active clinicians are listed under Nurse Practitioner with a practice address in Torrance, CA (8,237 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Torrance
15% of these 80 clinicians have the CMS telehealth indicator.
30% of these 80 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 488% from 137 in 2021 to 805 in 2024.
- 2021: 137
- 2022: 1,037
- 2023: 1,216
- 2024: 805
-
30-day fills
30-day fills increased 581% from 137 in 2021 to 933 in 2024.
- 2021: 137
- 2022: 1,049
- 2023: 1,270
- 2024: 933
-
Part D drug cost
Part D drug cost increased 443% from $171,975 in 2021 to $933,808 in 2024.
- 2021: $171,975
- 2022: $909,168
- 2023: $1,100,713
- 2024: $933,808
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $537.80 in 2021 to $1,329.98 in 2025.
- 2021: $537.80
- 2022: $881.66
- 2023: $1,116.72
- 2024: $1,578.85
- 2025: $1,329.98
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 45 records totaling $1,329.98.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $121.97 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Biktarvy | General | $121.96 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Yeztugo | General | $119.41 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $35.00 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Biktarvy | General | $34.14 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Biktarvy | General | $33.78 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
PIFELTRO | General | $33.76 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $33.47 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Biktarvy | General | $33.12 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $32.75 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $32.59 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $32.28 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $32.27 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $31.99 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $31.32 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $31.19 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $31.15 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $30.85 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $30.43 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
PIFELTRO | General | $28.24 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $28.08 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $28.02 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $27.96 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $27.94 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $26.84 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 111 | 3,330 | $434,104.61 | 16 |
| Atorvastatin Calcium | Atorvastatin Calcium | 77 | 2,700 | $230.74 | 11 |
| Symtuza | Darunavir/Cob/Emtri/Tenof Alaf | 60 | 1,800 | $252,505.57 | β |
| Benazepril Hcl | Benazepril Hcl | 56 | 2,070 | $158.54 | β |
| Amlodipine Besylate | Amlodipine Besylate | 49 | 1,860 | $97.59 | β |
| Gabapentin | Gabapentin | 36 | 1,260 | $247.36 | β |
| Furosemide | Furosemide | 31 | 930 | $85.52 | β |
| Jardiance | Empagliflozin | 30 | 1,170 | $16,816.52 | β |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 30 | 668 | $1,312.50 | β |
| Glipizide | Glipizide | 29 | 1,050 | $179.55 | β |
| Carvedilol | Carvedilol | 27 | 990 | $93.50 | β |
| Metformin Hcl | Metformin Hcl | 26 | 1,200 | $79.12 | β |
| Losartan Potassium | Losartan Potassium | 22 | 720 | $67.03 | β |
| Omeprazole | Omeprazole | 20 | 1,020 | $199.41 | β |
| Tivicay | Dolutegravir Sodium | 18 | 540 | $38,030.55 | β |
| Ezetimibe | Ezetimibe | 16 | 660 | $51.60 | β |
| Juluca | Dolutegravir/Rilpivirine | 16 | 480 | $56,011.03 | β |
| Lisinopril | Lisinopril | 15 | 630 | $10.39 | β |
| Hydrochlorothiazide | Hydrochlorothiazide | 15 | 570 | $13.41 | β |
| Odefsey | Emtricitab/Rilpiviri/Tenof Ala | 14 | 420 | $45,221.84 | β |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 13 | 390 | $45,933.09 | β |
| Dovato | Dolutegravir Sodium/Lamivudine | 13 | 390 | $37,034.70 | β |
| Tamsulosin Hcl | Tamsulosin Hcl | 12 | 840 | $174.80 | β |
| Verapamil Er | Verapamil Hcl | 12 | 360 | $55.57 | β |
| Trazodone Hcl | Trazodone Hcl | 12 | 360 | $8.57 | β |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-02-22NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1000 W CARSON ST # 449, TORRANCE, CA 905022004 (Tel: 4243064350)
Registered at 1000 W CARSON ST # 449, TORRANCE, CA 905022059 (Tel: 1424306436)
Registered at 8880 S BROADWAY, LOS ANGELES, CA 900033635 (Tel: 3237501196)
NPI status registered as active in NPPES database
Registered at 8880 S BROADWAY, LOS ANGELES, CA 900033635 (Tel: 3237501196)
Registered at 1215 245TH ST, HARBOR CITY, CA 907101807 (Tel: 4245589627)
Recorded as ERIC CABAHUG, NP
Nurse Practitioner (license number reported to NPPES: CA 95014847)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Torrance
- Eleia Bibay, FNP
- Makiko Suzuki, AGACNP, FNP
- Crystal Pena, APRN, NP-C
- Alyssa Washlake, NP
- Wendy Hamilton, RNP
- Valerie Mehl, NP
Mailing Address
1000 W Carson St # 449
Torrance, CA 905022059
Phone: 1424306436